Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Proteomics: addressing the challenges of osteoarthritis.
De Ceuninck F, Berenbaum F. De Ceuninck F, et al. Drug Discov Today. 2009 Jul;14(13-14):661-7. doi: 10.1016/j.drudis.2009.05.006. Epub 2009 May 27. Drug Discov Today. 2009. PMID: 19477289 Review.
S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) monoclonal antibody as a candidate treatment for selected autoimmune rheumatic diseases.
Duguet F, Ortega-Ferreira C, Fould B, Darville H, Berger S, Chomel A, Leclerc G, Kisand K, Haljasmägi L, Hayday AC, Desvaux E, Nony E, Moingeon P, De Ceuninck F. Duguet F, et al. Among authors: de ceuninck f. J Transl Autoimmun. 2021 Mar 1;4:100093. doi: 10.1016/j.jtauto.2021.100093. eCollection 2021. J Transl Autoimmun. 2021. PMID: 33748735 Free PMC article.
Applications of transcriptomics in support of drug development for osteoarthritis.
Kaplon H, Luo Y, De Ceuninck F, Lalande A, Courtade-Gaiani S, Laigle L, Moingeon P. Kaplon H, et al. Among authors: de ceuninck f. Osteoarthr Cartil Open. 2021 Nov 18;3(4):100221. doi: 10.1016/j.ocarto.2021.100221. eCollection 2021 Dec. Osteoarthr Cartil Open. 2021. PMID: 36474760 Free PMC article.
Pharmacological characterization of GLPG1972/S201086, a potent and selective small-molecule inhibitor of ADAMTS5.
Clement-Lacroix P, Little CB, Smith MM, Cottereaux C, Merciris D, Meurisse S, Mollat P, Touitou R, Brebion F, Gosmini R, De Ceuninck F, Botez I, Lepescheux L, van der Aar E, Christophe T, Vandervoort N, Blanqué R, Comas D, Deprez P, Amantini D. Clement-Lacroix P, et al. Among authors: de ceuninck f. Osteoarthritis Cartilage. 2022 Feb;30(2):291-301. doi: 10.1016/j.joca.2021.08.012. Epub 2021 Oct 6. Osteoarthritis Cartilage. 2022. PMID: 34626798 Free article.
Targeting galectin-3 in inflammatory and fibrotic diseases.
Bouffette S, Botez I, De Ceuninck F. Bouffette S, et al. Among authors: de ceuninck f. Trends Pharmacol Sci. 2023 Aug;44(8):519-531. doi: 10.1016/j.tips.2023.06.001. Epub 2023 Jun 28. Trends Pharmacol Sci. 2023. PMID: 37391294 Free article. Review.
Antibody-mediated neutralization of galectin-3 as a strategy for the treatment of systemic sclerosis.
Ortega-Ferreira C, Soret P, Robin G, Speca S, Hubert S, Le Gall M, Desvaux E, Jendoubi M, Saint-Paul J, Chadli L, Chomel A, Berger S, Nony E, Neau B, Fould B, Licznar A, Levasseur F, Guerrier T, Elouej S, Courtade-Gaïani S, Provost N, Nguyen TQ, Verdier J, Launay D, De Ceuninck F. Ortega-Ferreira C, et al. Among authors: de ceuninck f. Nat Commun. 2023 Aug 31;14(1):5291. doi: 10.1038/s41467-023-41117-9. Nat Commun. 2023. PMID: 37652913 Free PMC article.
Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)/alpha(2)-adrenoceptor.
Newman-Tancredi A, Cussac D, Audinot V, Nicolas JP, De Ceuninck F, Boutin JA, Millan MJ. Newman-Tancredi A, et al. Among authors: de ceuninck f. J Pharmacol Exp Ther. 2002 Nov;303(2):805-14. doi: 10.1124/jpet.102.039875. J Pharmacol Exp Ther. 2002. PMID: 12388667
43 results